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Human memory-like NK cells are commonly defined by either a lack of FcεRIγ
or gain of NKG2C expression. Here, we investigated the heterogeneity of human
CD56dim NK cell subpopulations according to the expression of FcεRIγ and NKG2C
in a large cohort (n = 127). Although the frequency of FcεRIγ− and NKG2C+ NK
cells positively correlated, the FcεRIγ− and NKG2C+ NK cell populations did not
exactly overlap. The FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− NK cell
populations were only evident after HCMV infection, but each had distinct characteristics.
Among the subpopulations, FcεRIγ−NKG2C+ NK cells exhibited the most restricted
killer immunoglobulin-like receptor repertoire, suggesting clonal expansion. Moreover,
FcεRIγ−NKG2C+ NK cells exhibited the lowest Ki-67 and highest Bcl-2 expression,
indicating the long-lived quiescent memory-like property. Functionally, FcεRIγ−NKG2C+
NK cells had weak natural effector function against K562 but strong effector functions
by CD16 engagement, whereas FcεRIγ+NKG2C+ NK cells had strong effector
functions in both settings. Anatomically, the FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and
FcεRIγ−NKG2C− NK cell populations were present in multiple human peripheral organs.
In conclusion, we demonstrate the heterogeneity of memory-like NK cells stratified by
FcεRIγ and NKG2C and suggest both markers be utilized to better define these cells.
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INTRODUCTION
NK cells are cytotoxic innate lymphocytes responsible for early immune reactions to viral infections
and tumors (1). Although immunological memory is a characteristic of adaptive immunity,
emerging data indicate that NK cells can also acquire immunological memory (2, 3). Human NK
cells can be classified in immature CD56bright andmature CD56dim cells (4, 5). Within the CD56dim
NK cell population, a subset of NK cells that gain NKG2C or lose FcεRIγ expression have been
suggested as memory-like NK cells, which exhibit features of long-term persistence and unique
epigenetic profiles (6, 7).
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These memory-like NK cells are found exclusively in people
infected with human cytomegalovirus (HCMV), and UL40
peptides have been described as specific antigens for the
expansion of memory-like NK cells (6, 8). These memory-like
NK cells can constitute a large proportion of the total NK cell
population and persist for several years (6, 9). The role of these
cells in human physiology is yet to be identified, but they are
suggested to serve as effectors for controlling HCMV (10).
Memory-like NK cells have been studied more extensively in
mousemodels than human subjects. Althoughmouse and human
memory-like NK cells share some characteristics, they also have
distinct properties, including an absence of FcεRIγ− cells in
the mouse memory-like NK cell population (2, 6). Therefore,
human-specific studies are required to better understand the
biology of memory-like NK cells in humans. Although the
expression of NKG2C and loss of FcεRIγ have been suggested
to be key features of memory-like NK cells in humans (6, 7),
NKG2C+ and FcεRIγ− cells do not overlap exactly and are
occasionally dissociated, implying heterogeneity withinmemory-
like NK cells (11).
In the present study, we recruited a large cohort of adult
donors to investigate the heterogeneity of human memory-
like NK cells according to FcεRIγ and NKG2C expression.
FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C−
NK cells were only evident in HCMV-seropositive donors.
FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C−
NK cells exhibited distinct characteristics, both phenotypically
and functionally. The FcεRIγ−NKG2C+ NK cell population
had the most restricted killer cell immunoglobulin-like
receptor (KIR) repertoire of all other subpopulations.
Moreover, these cells exhibited characteristics of long-lived
quiescent memory-like cells. Although FcεRIγ−NKG2C+ and
FcεRIγ−NKG2C− NK cells exhibited weak natural effector
functions, FcεRIγ+NKG2C+ NK cells showed strong natural
effector functions. However, FcεRIγ−NKG2C+ NK cells exerted
strong effector functions by CD16 engagement. The memory-
like NK cell subpopulations were detected in multiple human
peripheral organs, but were less frequent in secondary lymphoid
organs. These findings demonstrate the heterogeneity within
memory-like NK cells and suggest that combining both markers
may better define memory-like NK cells.
MATERIALS AND METHODS
Human Subjects and Sample Collection
Human peripheral blood samples were collected from 127
Koreans who were recruited from subjects initially registered
in the Yonsei Cardiovascular Genome cohort. The median
age was 62 years (range, 20–81 years) and 81 were males.
This study received prior approval from the Institutional
Review Board of the Yonsei University College of Medicine
(IRB number: 4-2001-0039, 4-2010-0500). All subjects gave
written informed consent in accordance with the Declaration
of Helsinki. Among the cohort, 123 subjects were seropositive
for HCMV. Serial peripheral blood was obtained from an
adult healthy donor with acute HCMV infection. Pre-infection
peripheral blood mononuclear cells (PBMCs) were also
available from this donor. Liver perfusates were obtained
from healthy donor livers during liver transplantation,
liver tissues from hepatitis B virus-infected explanted livers
during liver transplantation, pleural fluid from patients with
tuberculosis, tonsils were obtained during tonsillectomy, and
lymph nodes without tumor involvement and tumor tissues
were obtained during surgery for non-small cell lung cancer.
PBMCs and liver sinusoidal lymphocytes (LSLs) were isolated
from peripheral blood and liver perfusates, respectively, using
standard Ficoll-Paque (GE Healthcare, Uppsala, Sweden)
density gradient centrifugation. Tissues were dissociated
into single cells using a gentleMACS dissociator (Miltenyi,
Bergisch Gladbach, Germany) as described previously (12).
The serological status for CMV, HSV1, HSV2, and EBV was
measured using virus-specific ELISA kits (IBL International,
Hamburg, Germany). All participants provided informed
consent before enrollment.
Flow Cytometry
Antibodies to the following surface molecules were used for
cell staining: CD3 (HIT3a), CD56 (NCAM16.2), CD158b (CH-
L), CD14 (MφP9), CD19 (HIB19) (all from BD Biosciences,
San Jose, CA), NKG2C (134591), CD158a (143211) (all from
R&D Systems, Abingdon, UK), CD158e1 (DX9), Bcl-2 (100),
Ki-67 (Ki-67) (all from BioLegend, San Diego, CA), CD57
(TBO1, eBioscience, San Diego, CA), and FcεRIγ (Merck
Millipore, Billerica, MA). Dead cells were excluded using the
LIVE/DEAD Fixable Red Dead Cell Stain Kit (Invitrogen,
Carlsbad, CA). Intracellular staining for Ki-67, Bcl-2, and
FcεRIγ was performed using a FoxP3 transcription factor
staining buffer set (eBioscience, San Diego, CA) and specific
antibodies. All samples were acquired on an LSR II cytometer
and analyzed using FlowJo software version 10.4.0 (Treestar,
San Carlos, CA).
Functional Assays
PBMCs were thawed and rested overnight in RPMI
supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin. The PBMCs were co-cultured with
K562 cells or anti-CD16-coated P815 cells for 12 h at an effector
to target ratio of 10:1 in the presence of anti-CD107a (H4A3,
BD Biosciences, San Jose, CA). Brefeldin A and monensin were
added 1 h after co-incubation. For the anti-CD16 coating, P815
cells were incubated at 37◦C with 10µg/mL anti-CD16 antibody
for 30min. Cytokine production was detected by intracellular
staining using antibodies to IFN-γ (B27) and TNF-α (Mab11)
(all from BD Biosciences, San Jose, CA).
Statistical Analysis
Statistical comparisons were performed as indicated in the figure
legends. To quantify the diversity of KIRs, the inverse Simpson
index was calculated, in which a lower value indicates less
diversity. Two-sided P < 0.05 were considered significant. All
statistical analyses were performed in Prism software version 6.0
(GraphPad, La Jolla, CA).
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FIGURE 1 | Expression of FcεRIγ and NKG2C among CD56dim NK cells in peripheral blood. (A) Correlation of the frequency of FcεRIγ− NK cells and NKG2C+ NK
cells (n = 123). (B) Representative flow cytometry plots of FcεRIγ and NKG2C expression in gated CD56dim NK cells from three HCMV-seropositive donors. (C)
Frequency of the four subpopulations according to expression of FcεRIγ and NKG2C among CD56dim NK cells in HCMV-seropositive donors (n = 123). Bar graphs
indicate mean and s.d. Statistical analysis was performed by one-way ANOVA and post-hoc analysis by Tukey’s multiple comparisons test (C). Only significant
differences are indicated. ****P < 0.0001.
RESULTS
Expression of FcεRIγ and NKG2C in
Peripheral Blood CD56dim NK Cells
First, we examined the expression of FcεRIγ and NKG2C
in live CD56dimCD3−CD14−CD19− cells (CD56dim NK cells)
among PBMCs from 123 HCMV-seropositive donors. The
percentage of FcεRIγ− NK cells significantly correlated with the
percentage of NKG2C+ NK cells (Figure 1A). However, FcεRIγ−
cells were not always NKG2C+ and vice versa (Figure 1B).
Among CD56dim NK cells, the FcεRIγ+NKG2C− population
was most frequent and FcεRIγ+NKG2C+ population least
frequent, whereas the FcεRIγ−NKG2C+ and FcεRIγ−NKG2C−
populations had similar frequencies (Figure 1C). In summary,
the FcεRIγ− and NKG2C+ populations overlap to some degree
but are dissociated.
FcεRIγ−NKG2C+ NK Cells Are Clonally
Expanded From FcεRIγ+NKG2C− NK Cells
We obtained serial peripheral blood from a healthy adult
donor who experienced acute HCMV infection. Pre-infection
PBMCs from this donor were also available from storage. Before
HCMV infection, the donor had a low frequency of FcεRIγ−
NK cells and NKG2C+ NK cells (Figure 2A). Following acute
HCMV infection, the FcεRIγ+NKG2C+ population appeared
first, followed by the FcεRIγ−NKG2C+ population (Figure 2A).
The frequency of FcεRIγ+NKG2C+ and FcεRIγ−NKG2C+
cells continuously increased for 3 years post-infection. The
frequency of FcεRIγ−NKG2C− cells also slightly increased. This
representative example indicates that FcεRIγ+NKG2C− cells first
acquire NKG2C expression, and then subsequently lose FcεRIγ
expression following acute HCMV infection.
Next, we analyzed relevant markers for memory-like NK
cells during the course of acute HCMV infection in the
healthy donor. Memory-like NK cells have been reported to
have higher expression of CD2 (13) and lower expression
of NKG2A, CD161, and PLZF (6, 7, 14). FcεRIγ−NKG2C+
cells exhibited high CD2 expression, low NKG2A+ and
CD161+ cell frequency, and low PLZF expression early
after acute HCMV infection (Figure 2B). During acute
HCMV infection, all NK cell subpopulations showed a
robust increase in the frequency of proliferating Ki-67+
cells and downregulation of Bcl-2 (Figure 2C). Among the
subpopulations, FcεRIγ−NKG2C+, FcεRIγ+NKG2C+, and
FcεRIγ−NKG2C− cells, showed higher frequencies of Ki-67+
cells and higher expression of Bcl-2 than FcεRIγ+NKG2C−
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FIGURE 2 | Frequency and phenotypes of CD56dim NK cell subpopulations before and following acute HCMV infection. (A) Sequential change in FcεRIγ and NKG2C
expression among CD56dim NK cells in an adult healthy donor before and after acute HCMV infection. Time points indicate time from symptom onset. (B) Frequency
of CD2+ cells, geometric mean fluorescence intensity (gMFI) of CD2, frequency of NKG2A+ cells, CD161+ cells, and gMFI of PLZF in FcεRIγ+NKG2C−,
FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− cells before and following acute HCMV infection. (C) Frequency of Ki-67+ cells and gMFI of Bcl-2 in
FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− cells. (D) Frequency of KIR combinations before and following acute HCMV infection
among CD56dim NK cells.
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FIGURE 3 | KIR repertoire of CD56dim NK cell subpopulations. (A) Representative flow cytometry plots of KIR2DL1, KIR2DL2/DL3, and KIR3DL1 expression in
FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− cells. The pie chart presents the distribution of the eight KIR subtypes. (B) Distribution
of KIR subtypes in the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations (n = 123). (C) Diversity index of the KIR
repertoire in the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations. The inverse Simpson index was calculated to evaluate
diversity. The lines in the boxplot indicate median values, the boxes indicate IQR values, and the whiskers extend to 1.5× IQR values. Statistical analysis was
performed by one-way ANOVA and post-hoc analysis by Tukey’s multiple comparisons test (C). Only significant differences are indicated. *P < 0.05; **P < 0.01;
****P < 0.0001.
cells (Figure 2C). We also analyzed the change in KIR
repertoire during acute HCMV infection. KIRs are expressed
on the surface of NK cells through a stochastic process, and
the expression is maintained through DNA methylation
(15, 16). This creates a diverse repertoire of NK cell clones
characterized by individual combinations of KIRs. We
investigated the expression of three commonly expressed
KIRs, KIR2DL1, KIR2DL2/L3, and KIR3DL1, which resulted
in eight KIR combinations. The KIR repertoire was skewed
toward KIR2DL1−KIR2DL2/DL3+KIR3DL1− within the
CD56dim NK cells, which was the dominant combination
in the FcεRIγ−NKG2C+ subpopulation, following HCMV
infection (Figure 2D).
We then analyzed the KIR repertoire in the four
subpopulations of CD56dim NK cells of the cohort of
123 HCMV-seropositive subjects. In a representative
HCMV-seropositive donor, the KIR repertoire was most
restricted in the FcRγ−NKG2C+ subpopulation, and
the KIR2DL1−KIR2DL2/DL3+KIR3DL1− combination
predominated (Figure 3A). In the whole cohort, the four
subpopulations had distinct patterns of KIR repertoire
(Figure 3B). The KIR2DL1−KIR2DL2/DL3−KIR3DL1−
combination was more common in the FcεRIγ+NKG2C−
and FcεRIγ−NKG2C− subpopulations, whereas the
KIR2DL1−KIR2DL2/DL3+KIR3DL1− combination was
more common in the FcεRIγ−NKG2C+ and FcεRIγ+NKG2C+
subpopulations (Figure 3B). Furthermore, FcεRIγ−NKG2C+
cells exhibited the most restricted KIR diversity compared to
the other subpopulations (Figure 3C). The FcεRIγ−NKG2C−
subpopulation also exhibited restricted KIR diversity compared
to the FcεRIγ+NKG2C− subpopulation. Taken together, the
results indicate that FcεRIγ −NKG2C+ NK cells may acquire
their characteristics early after HCMV infection and may be
clonally expanded from FcεRIγ+NKG2C− NK cells.
FcεRIγ−NKG2C+ NK Cells Exhibit Features
of Long-Term Memory and Terminal
Differentiation
We further investigated the phenotype of the four different
CD56dim NK cell subpopulations. Long-lived memory CD8+
T cells are quiescent and apoptosis-resistant cells characterized
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FIGURE 4 | FcεRIγ−NKG2C+CD56dim NK cells exhibit features of long-term memory and terminal differentiation. (A) Percentage of Ki-67+ cells among the
FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations (n = 13). (B) Geometric mean fluorescence intensity (gMFI) of Bcl-2
among the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations (n = 13). (C) Percentage of CD57+ cells among the
FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations (n = 13). Representative FACS plots are presented on the left (A–C).
Data are presented as mean ± s.d. Statistical analyses were performed by one-way ANOVA and post-hoc analysis by Tukey’s multiple comparisons test (A–C). Only
significant differences are indicated. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
by low Ki-67 and high Bcl-2 expression (17, 18). Similar to
memory CD8+ T cells, FcεRIγ−NKG2C+ NK cells exhibited
lower expression of Ki-67 (Figure 4A) and higher expression
of Bcl-2 (Figure 4B) compared to the other subpopulations.
FcεRIγ+NKG2C+ and FcεRIγ−NKG2C− NK cells also exhibited
lower expression of Ki-67 (Figure 4A), and FcεRIγ+NKG2C+
NK cells exhibited higher expression of Bcl-2 (Figure 4B)
compared to FcεRIγ+NKG2C− NK cells. Furthermore,
FcεRIγ−NKG2C+ NK cells had the highest expression of
CD57, which is a marker of highly mature and terminally
differentiated NK cells (19), although FcεRIγ+NKG2C+ and
FcεRIγ−NKG2C− NK cells had upregulated CD57 expression
compared to FcεRIγ+NKG2C− NK cells (Figure 4C). These data
indicate that FcεRIγ−NKG2C+ NK cells are more terminally
differentiated than the other subpopulations and have features of
long-lived memory cells.
FcεRIγ−NKG2C+ NK Cells Have Reduced
Activity Against K562 Target Cells but
Enhanced CD16-Mediated Effector
Functions
To investigate the functionality of the four different
subpopulations of CD56dim NK cells, we measured cytokine
production (IFN-γ and TNF-α) and degranulation (CD107a)
in each subpopulation when co-cultured with K562 target cells
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FIGURE 5 | Effector functions of CD56dim NK cell subpopulations in response to K562 target cells. (A) Representative flow cytometry plots of IFN-γ and TNF-α
production, and CD107a expression after co-culture with K562 cells for 12 h among the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and
FcεRIγ−NKG2C− subpopulations. (B–D) Percentage of IFN-γ+ (B), TNF-α+ (C), and CD107a+ (D) cells among the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+,
FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations (n = 12) after co-culture with K562 cells. (E) Percentage of polyfunctional cells that co-express IFN-γ,
TNF-α, or CD107a. (F,G) gMFI of NKG2D (F) and NKp30 (G) among the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C−
subpopulations. Statistical analyses were performed by one-way ANOVA and post-hoc analysis by Tukey’s multiple comparisons test (B–G). Only significant
differences are indicated. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
(Figure 5A). FcεRIγ−NKG2C+ and FcεRIγ−NKG2C− NK
cells exhibited weak cytokine production and degranulation
in response to K562 target cells (Figures 5A–D). In addition,
FcεRIγ−NKG2C+ and FcεRIγ−NKG2C− NK cells had minimal
polyfunctionality, defined as cells simultaneously positive for
IFN-γ, TNF-α, and/or CD107a (Figure 5E).
FcεRIγ+NKG2C+ NK cells had the highest functionality
against K562 target cells. NKG2D receptor, which
mediates the cytolytic activity of NK cells against target
cells expressing NKG2D ligands (20), was most highly
expressed in FcεRIγ+NKG2C+ NK cells, and expressed
at significantly lower levels in FcεRIγ−NKG2C+ and
FcεRIγ−NKG2C− NK cells compared to FcεRIγ+NKG2C+
NK cells (Figure 5F). In addition, NKp30, which also
has been documented in its function in killing B7-H6
expressing tumor cells (21), was more highly expressed
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FIGURE 6 | CD16-mediated effector functions of CD56dim NK cell subpopulations. (A) Representative flow cytometry plots of IFN-γ and TNF-α production, and
CD107a expression after co-culture with anti-CD16-coated P815 cells for 12 h among the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and
FcεRIγ−NKG2C− subpopulations. (B–D) Percentage of IFN-γ+ (B), TNF-α+ (C), and CD107a+ (D) cells among the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+,
FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations (n = 12) after co-culture with anti-CD16-coated P815 cells. (E) Percentage of polyfunctional cells that
co-express IFN-γ, TNF-α, or CD107a. (F) gMFI of CD16 among the FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− subpopulations.
Statistical analyses were performed by one-way ANOVA and post-hoc analysis by Tukey’s multiple comparisons test (B–F). Only significant differences are indicated.
*P < 0.05; **P < 0.01; ***P < 0.001.
in FcεRIγ+NKG2C− and FcεRIγ+NKG2C+ NK cells
(Figure 5G).
Next, we analyzed NK cell functionality following co-
culture with anti-CD16-coated P815 cells (Figure 6A).
FcεRIγ−NKG2C+ NK cells had the highest TNF-α
production among all subpopulations (Figure 6C) and
higher IFN-γ production (Figure 6B) and degranulation
activity (Figure 6D) than the FcεRIγ+NKG2C− and
FcεRIγ−NKG2C− subpopulations. Moreover, FcεRIγ−NKG2C+
NK cells exhibited the highest polyfunctionality (Figure 6E).
FcεRIγ+NKG2C+ NK cells also had higher cytokine
production, degranulation, and polyfunctionality than
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FIGURE 7 | Virological, demographic, and anatomical factors associated with subpopulations of CD56dim NK cells. (A) Frequency of FcεRIγ+NKG2C−,
FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− cells among CD56dim NK cells according to serological status for HCMV (positive, n = 123; negative, n =
4), HSV1 (positive, n = 122; negative, n = 5), HSV2 (positive, n = 104; negative, n = 23), and EBV (positive, n = 122; negative, n = 5). The bars indicate mean and
s.d. (B) Correlation between age and the frequency of FcεRIγ+NKG2C−, FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, or FcεRIγ−NKG2C− cells in HCMV seropositive donors
(n = 123). (C–H) Representative FACS plots of FcεRIγ and NKG2C expression in gated CD56dim NK cells among LSLs and paired PBMCs (n = 3; C), tonsils and
paired PBMCs (n = 3; D), non-tumor involved lymph nodes (n = 3; E), liver-infiltrating lymphocytes (LILs; n = 3; F), pleural fluid (n = 3; G), and tumor-infiltrating
lymphocytes (TILs) from patients with non-small cell lung cancer (NSCLC; n = 3; H).
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FcεRIγ+NKG2C− NK cells (Figures 6B–E). However,
FcεRIγ−NKG2C− NK cells exhibited higher TNF-α production
than FcεRIγ+NKG2C− NK cells (Figure 6C). Although the
majority of CD56dim NK cells express CD16, FcεRIγ−NKG2C+,
and FcεRIγ−NKG2C− subpopulations exhibited lower mean
fluorescence intensity of CD16 (Figure 6F). Taken together,
the results indicate that FcεRIγ−NKG2C+ NK cells have
diminished K562-induced natural effector functions but
enhanced CD16-mediated effector functions compared to
other subpopulations.
Virological, Demographic, and Anatomical
Factors Associated With FcεRIγ−NKG2C+
NK Cells
To gain insights into the context in which the subpopulations
of CD56dim NK cells emerge, we investigated the correlation
between the frequency of each subpopulations and virological
and demographical factors in 127 donors. FcεRIγ+NKG2C+,
FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− NK cells were not
present in HCMV-seronegative individuals, whereas individuals
seronegative for other herpesviruses had significant amounts of
these populations. Among the 122 donors that were seropositive
to HSV1, 121 were seropositive to HCMV and one donor that
was seropositive to HSV1 but seronegative to HCMV had 2.68,
0.02, and 0.67% of FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and
FcεRIγ−NKG2C− cells among CD56dim NK cells, respectively.
All donors that were seropositive to HSV2 or EBV were
seropositive to HCMV. These data suggest that HCMV drives
the generation of FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and
FcεRIγ−NKG2C− NK cells (Figure 7A). Chronological aging
has been shown to correlate with decreased naïve T-cell
pools and increased memory T cells (22), but none of the
CD56dim NK cell subpopulations significantly correlated with
age (Figure 7B).
Next, we examined the frequency of the four
different CD56dim NK subpopulations in peripheral
organs (Supplementary Figure 1). FcεRIγ+NKG2C+,
FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− NK cells were
present at multiple sites, such as the liver sinusoid (Figure 7C),
tonsils (Figure 7D), lymph nodes (Figure 7E), liver tissues
(Figure 7F), pleural fluid (Figure 7G), and tumor tissues
(Figure 7H). Matched PBMCs and LSLs were available from
three donors, and the frequencies of FcεRIγ+NKG2C+,
FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− NK cells were
similar between the two compartments (Figure 7C). However,
in tonsil tissues, the frequency of FcεRIγ−NKG2C+ NK
cells was lower than in the matched PBMCs (Figure 7D). In
addition, the frequency of FcεRIγ−NKG2C+ NK cells was
relatively low in lymph nodes (Figure 7E). FcεRIγ+NKG2C+,
FcεRIγ−NKG2C+, and FcεRIγ−NKG2C− NK cells were also
detected in liver tissues (Figure 7F), pleural fluid (Figure 7G),
and tumor tissues (Figure 7H). These data suggest that
FcεRIγ+NKG2C+, FcεRIγ−NKG2C+, and FcεRIγ−NKG2C−
NK cells are present in various human peripheral organs, and
that FcεRIγ−NKG2C+ NK cells are preferentially present in
non-lymphoid organs.
DISCUSSION
In the present study, we focused on the heterogeneity of
human memory-like NK cells according to FcεRIγ and NKG2C
expression and characterized these subpopulations. Although
loss of FcεRIγ (6, 23, 24) and gain of NKG2C expression
(25–27) have been suggested as markers of human memory-
like NK cells in humans, we found that FcεRIγ− NK cells
and NKG2C+ NK cells do not exactly overlap and are rather
dissociated, indicating the need for research based on both
markers. Furthermore, we demonstrated that FcεRIγ−NKG2C+
NK cells exhibit typical features of long-lived quiescent memory-
like cells with decreased function against K562 target cells
but enhanced CD16-mediated effector capacity. The other
subpopulations, FcεRIγ+NKG2C+ and FcεRIγ−NKG2C− NK
cells, exhibited intermediate characteristics between memory-
like FcεRIγ−NKG2C+ and non-memory FcεRIγ+NKG2C−
NK cells.
The FcεRIγ−NKG2C+ NK cells had unique features
compared to the other subpopulations. First, the
FcεRIγ−NKG2C+ subpopulation was most clonally restricted
in terms of the KIR repertoire. This is supported by
a recent study demonstrating that NKG2C+ NK cells
undergo clonal-like expansion by recognizing certain
HCMV UL40-encoded peptides presented by HLA-E
(25). Second, the FcεRIγ−NKG2C+ NK cells had the
lowest Ki-67 expression and highest Bcl-2 expression,
implying that this population has quiescent memory-like
features. We also examined the expression of CD57, a
marker of terminal differentiation (19, 28), and found that
FcεRIγ−NKG2C+ cells most highly express CD57. The
FcεRIγ−NKG2C+ NK cells were not only phenotypically
unique, but also functionally unique. We found that the
FcεRIγ−NKG2C+ subpopulation had strong CD16-mediated
effector functions, especially in terms of TNF-α production and
polyfunctionality. However, FcεRIγ−NKG2C+ NK cells
exhibited weak cytokine production and degranulation
activity against K562. These data from FcεRIγ−NKG2C+
NK cells coincide with previous results demonstrating that
FcεRIγ−memory-like NK cells have an antibody-dependent,
enhanced response to target cells (6, 7, 23, 24, 29). Overall,
the phenotypical and functional analyses indicated that
FcεRIγ−NKG2C+ NK cells are a proper memory-like NK
cell population.
The FcεRIγ+NKG2C+ NK cell population exhibited different
characteristics from the FcεRIγ−NKG2C+ NK cell population,
though both populations expressed NKG2C. Despite the
similarity in the KIR repertoires between both populations,
FcεRIγ−NKG2C+ NK cells exhibited lower diversity than
FcεRIγ+NKG2C+ NK cells, indicating further clonal expansion
of FcεRIγ−NKG2C+ NK cells from FcεRIγ+NKG2C+ NK cells.
In a donor with acute CMV infection, FcεRIγ+NKG2C+ NK
cells first appeared after acute HCMV infection, followed by
the appearance of FcεRIγ−NKG2C+ NK cells. FcεRIγ−NKG2C+
NK cells exhibited a robust increase in proliferation following
HCMV infection and showed the most restricted KIR repertoire,
supporting the clonal-like expansion of these cells. In addition,
we found that characteristics of memory-like NK cells, such
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as high CD2 expression and low CD161, NKG2A, and PLZF
expression (6, 7, 13, 14), were evident early after HCMV
infection, suggesting that the epigenetic modification described
in memory-like NK cells (6, 7) may take place during the
early developmental period. Functionally, FcεRIγ+NKG2C+ NK
cells exerted the highest effector function against K562 target
cells among the NK subpopulations. Collectively, our data
suggest that FcεRIγ+NKG2C+ NK cells may be effector cells
against HCMV-infected cells that precede FcεRIγ−NKG2C+
NK cells.
Although the detailed mechanisms underlying the unique
properties of memory-like NK cells have not been fully
elucidated, FcεRIγ−or NKG2C+ NK cells were previously shown
to have decreased expression of transcription factors (PLZF
and Helios) and signaling molecules (SYK, EAT-2, and DAB-2)
that are epigenetically regulated (6, 7). In the current study, we
found a dissociation between the phenotypical and functional
characteristics of NK subpopulations based on FcεRIγ or NKG2C
expression. First, the weak K562-triggered effector function was
more similar between the FcεRIγ− NK cell populations
(FcεRIγ−NKG2C+ and FcεRIγ−NKG2C−), whereas strong
CD16-mediated effector functions were more similar between
the NKG2C+ cell populations (FcεRIγ+NKG2C+ and
FcεRIγ−NKG2C+). This implies that different mechanisms
may be involved in the regulation of direct natural and
antibody-dependent effector functions of memory-like NK
cells. Notably, FcεRIγ+NKG2C+ NK cells, which had the
highest activity against K562 cells, exhibited higher NKG2D
and NKp30 expression, which are known to mediated K562
killing. The lower expression of NK receptors in FcεRIγ−NK
cells was also documented in previous reports (7, 11). The
expression of receptors responsible for each function may
partially contribute to the distinct functionality of the NK
subpopulations. However, FcεRIγ−NKG2C+ NK cells, which
had the highest CD16-mediated effector functions, exhibited
a relatively lower expression of CD16 compared to other
subpopulations, which were also examined in a previous report
(11). These findings suggest other mechanisms underlying
its enhanced CD16-mediated effector functions. A possible
explanation may be the lack of NK cell education, since lower
fraction of the FcεRIγ+NKG2C− and FcεRIγ−NKG2C− were
KIR+. In this context, it will also be helpful to examine
the expression of NKG2A and monitor the functional
responses in NKG2A+ vs. NKG2A− cells expressing self or
non-self KIRs.
The patterns of tissue localization of memory-like NK
cells in humans have not been well-studied. However, in
mouse models, the murine CMV (MCMV)-specific memory-
like NK cells have been reported to be distributed in both
lymphoid and non-lymphoid organs after MCMV infection
(3). In human, CD49a+KIR+NKG2C+ NK cells have been
described in liver tissue, but the expression of FcεRIγ was
not examined (30). Although the number of evaluated donors
was small, we found that, in humans, the frequency of
memory-like NK cells, especially FcεRIγ−NKG2C+ NK cells,
tends to be smaller in secondary lymphoid organs, such as
lymph nodes and tonsils, compared to peripheral non-lymphoid
organs. Notably, the frequency of FcεRIγ−NKG2C− NK
cells in the secondary lymphoid organs was relatively high
compared to FcεRIγ+NKG2C+ and FcεRIγ−NKG2C+ NK cells,
supporting the heterogeneity of the subpopulations in terms of
organ distribution.
The specific role of memory-like NK cells in humans
remains unclear. It is possible that memory-like NK cells
are physiologically relevant in some contexts. A previous
study showed that NKG2C+ NK cells expand in recipients of
hematopoietic cell transplantation following HCMV reactivation
(26). Moreover, memory-like NKG2C+ NK cells have been
shown to be involved in the control of HCMV in kidney
transplant recipients, implying the role of memory-like NK
cells in controlling HCMV infection after organ transplantation
(25). Recently, the presence of memory-like NK cells in
patients co-infected with HCMV and HBV was reported (24).
The antibody-dependent NK-cell response was enhanced in
patients with HBV infection compared to healthy donors,
though the clinical significance of this phenomenon needs to
be researched further. The role of memory-like NK cells in
the context of cancer has also been proposed. Expansion of
memory-like NK cells after HCMV reactivation was associated
with a reduced risk of leukemia relapse (31), and adoptively
transferred memory-like NK cells demonstrated a robust clinical
response in patients with myeloid leukemia (32). Moreover,
a recent study showed that memory-like NK cells exhibit
resistance to regulatory T-cell-mediated suppression, whereas the
canonical NK cells were suppressed (8). Further investigation
of the function and relevance of memory-like NK cells in
various human diseases is required, including viral diseases
and cancers.
This study had some limitations. We were not able to
correlate HCMV viremia with the change in NK phenotypes
during acute HCMV infection due to the lack of data on
the virus titer. In addition, although paired PBMCs were
available for liver sinusoidal lymphocytes and tonsil tissues,
we did not have paired PBMCs for other peripheral tissues.
The serology data of HCMV was not available for the
donors of peripheral organs, although more than 97%
of the Korean population is known to be seropositive to
HCMV (33). Furthermore, we were not able to analyze
the expression patterns of KIRs in accordance to the
HLA-C genotype.
In conclusion, this study demonstrated heterogeneity within
memory-like NK cells. The results indicate that both FcεRIγ
and NKG2C should be utilized as markers to better define
memory-like NK cells. This was also the first study to
provide evidence of memory-like NK cells in diverse human
peripheral organs, which will facilitate further research of
memory-like NK cells in various contexts of human physiology
and pathology.
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